文献速递生殖医学

植入前遗传学检测中分析平台的持续监测:第4阶段

Ongoing surveillance of analytical platforms in preimplantation genetic testing: phase 4.
PubMed 文献 · Fertil Steril · 2025-01-01

本文探讨生殖遗传学检测(尤其是植入前遗传学检测)方案建立后,需持续监测分析平台与临床结局,强调数据积累、质控与质量保证、随访监测及异常妊娠结果管理,并简要讨论遗传学与体外受精实验室主任及临床医生的法律与伦理义务。

要点

  • 检测方案建立后需持续监测临床结局与分析稳定性以确保结果可靠和患者安全。
  • 需广泛积累数据并实施稳健的质量控制与质量保证措施。
  • 需对异常妊娠结果进行随访监测和仔细的后续管理。

核心结论

  • 对分析平台和临床结果进行适当且持续的质量控制、质量保证与监测,是确保临床性能与检测技术及临床验证中所观察到的性能一致、从而兑现对患者承诺获益的根本。

研究设计与样本

  • 本文为论述性文章,探讨生殖遗传学检测中心及合作的体外受精诊所和实验室持续监测临床结局与检测稳定性的必要性。

主要发现

  • 文章强调需要广泛的数据积累、稳健的质量控制与质量保证措施、随访监测以及对异常妊娠结果的仔细后续管理。
  • 文章简要讨论了遗传学和体外受精实验室主任以及临床医生确保生殖遗传学检测方案准确性和有效性的法律与伦理义务。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The advancement of reproductive genetics testing, particularly preimplantation genetic testing, has revolutionized the field of assisted reproductive technologies. However, once a testing protocol is established, analytical and clinical validation, rigorous monitoring and evaluation become imperative to ensure the reliability of results and patient safety. This article explores the necessity to continually monitor the clinical outcomes and assay stability within reproductive genetics testing centers and collaborating in vitro fertilization clinics and laboratories, emphasizing the need for extensive data accumulation, robust quality control and quality assurance measures, follow-up monitoring and careful follow-up management of abnormal pregnancy results. Furthermore, it briefly discusses the legal and ethical obligations of genetics and in vitro fertilization laboratory directors as well as clinicians to ensure the accuracy and effectiveness of reproductive genetics testing protocols. In essence, proper and continuous quality control/quality assurance/surveillance of analytical platforms and clinical results is fundamental to guarantee that clinical performance is consistent with that observed in technical and clinical validations of assays, ensuring that promised benefits to patients are delivered.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Capalbo A, Sparks AET, Babariya D, et al. Ongoing surveillance of analytical platforms in preimplantation genetic testing: phase 4. Fertil Steril. 2025. PMID: 41106954. doi:10.1016/j.fertnstert.2025.05.158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。